I

Intra-Cellular Therapies
D

ITCI

83.470
USD
-0.68
(-0.81%)
Market Closed
Volume
34,053
EPS
-1
Div Yield
-
P/E
-97
Market Cap
8,849,247,587
Related Instruments
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    A
    ALKS
    -0.220
    (-0.73%)
    29.750 USD
    BMY
    BMY
    0.990
    (1.76%)
    57.280 USD
    E
    ESPR
    0.00000
    (0.00%)
    2.18000 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    LLY
    LLY
    11.01
    (1.45%)
    768.44 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    More
News

Title: Intra/Cellular Therapies

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.